Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2019-08-27 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于公司部分产品在2019年国家医保目录中调整情况的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding changes in the national medical insurance drug catalog for the year 2019. It lists products newly included and excluded from the catalog, discusses the impact on the company's sales and operations, and provides risk warnings to investors. The document is relatively short (1710 characters) and does not contain financial statements, detailed financial analysis, or regulatory certifications. It is an announcement about product listing changes affecting the company rather than a financial report or management discussion. Therefore, it fits best into the category of a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-08-27 Chinese
关于股票交易异常波动的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company 福安药业 (Fuan Pharmaceutical) regarding abnormal stock price fluctuations over two trading days, explaining the situation, confirming no undisclosed material information, and reminding investors to be cautious. It is a regulatory disclosure about stock trading behavior and compliance with information disclosure rules, not a financial report, earnings release, or management discussion. The document is short (1210 characters) and serves as a formal notice to the market about stock price volatility and company statements on the matter. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2019-08-26 Chinese
关于公司控股股东部分股份解除质押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the release of pledged shares by a controlling shareholder. It details the number of shares released from pledge, the dates, and the proportion of shares involved. There is no financial report, earnings data, or management discussion. The content fits the category of a capital structure update related to share pledges and releases. Therefore, it is best classified as a Capital/Financing Update (CAP). The document length and content confirm it is not a report publication or regulatory filing. Confidence is high due to clear match with capital/financing activity.
2019-08-07 Chinese
关于收到注射用艾司奥美拉唑钠一致性评价受理通知书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (780 characters) regarding the receipt of a regulatory acceptance notice from the National Medical Products Administration for a drug consistency evaluation application. It does not contain financial data, detailed financial results, or management discussion. It is an official company announcement about a regulatory acceptance related to product approval, not a financial report or detailed regulatory filing. The document is not a report itself but an announcement of a regulatory event. Given the content and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-08-05 Chinese
关于控股股东部分股份质押及解除质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge and release of shares by a controlling shareholder. It details the number of shares pledged, dates, pledgees, and percentages of shareholding involved. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledging activities, which fits the category of Capital/Financing Update (CAP). The document length is short and it is not an announcement of a report publication but a direct disclosure of share pledge information.
2019-08-05 Chinese
关于控股股东部分股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the pledge of shares by a controlling shareholder. It details the number of shares pledged, the pledgee, and the proportion of shares pledged relative to total holdings and total share capital. There is no financial report, earnings data, or management discussion. The content fits the category of a capital or financing update, as it relates to changes in the company's capital structure through share pledging. The document length is short and it is not a report publication announcement or certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2019-08-01 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.